Intercept Pharmaceuticals, Inc.: capex

Value{"amount": 62817, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2011-01-01 – 2011-12-31
Statuscurrent
EntityIntercept Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001144204-13-019166 · Open the official SEC filing →
Retrieved: 2026-08-19T12:06:46.156809+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001270073/capex/2011-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/33306ec0-e8a5-47bc-9ff9-964c804a2b16

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies